Financials FGL Holdings Nyse

Equities

FG

KYG3402M1024

Life & Health Insurance

Delayed Nyse 5-day change 1st Jan Change
- USD -.--% Intraday chart for FGL Holdings -20.62% -21.22%

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 2,501 5,773 4,929 -
Enterprise Value (EV) 1 2,655 5,773 4,929 4,929
P/E ratio 4.79 x -97.9 x 8.45 x 7.41 x
Yield - - - -
Capitalization / Revenue 1.07 x 1.28 x 0.94 x 0.86 x
EV / Revenue 1.07 x 1.28 x 0.94 x 0.86 x
EV / EBITDA - - - -
EV / FCF 3,824,542 x - - -
FCF Yield 0% - - -
Price to Book 1.39 x - 1.42 x 1.23 x
Nbr of stocks (in thousands) 125,000 125,497 126,281 -
Reference price 2 20.01 46.00 39.03 39.03
Announcement Date 23-02-22 24-02-21 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2022 2023 2024 2025
Net sales 1 2,113 2,340 4,500 5,236 5,738
EBITDA - - - - -
EBIT 510 - - - -
Operating Margin 24.14% - - - -
Earnings before Tax (EBT) 1 568 598 -35 676 824
Net income 1 476 481 -58 572 655
Net margin 22.53% 20.56% -1.29% 10.93% 11.42%
EPS 2 - 4.180 -0.4700 4.620 5.270
Free Cash Flow - 654 - - -
FCF margin - 27.95% - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - 135.97% - - -
Dividend per Share - - - - -
Announcement Date 20-02-26 23-02-22 24-02-21 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 - 623 869 1,168 851 1,612 1,168 1,213 1,364 1,490 1,369
EBITDA - - - - - - - - - - -
EBIT - - - - - - - - - - -
Operating Margin - - - - - - - - - - -
Earnings before Tax (EBT) 1 - -176 -203 163 380 -375 157 164.5 172.5 181.5 187
Net income 1 115 -100 -195 130 306 -299 134 141 146 151 -
Net margin - -16.05% -22.44% 11.13% 35.96% -18.55% 11.48% 11.62% 10.7% 10.13% -
EPS 2 0.7600 -0.8000 -1.560 1.040 2.450 -2.410 1.080 1.130 1.180 1.220 1.240
Dividend per Share - - - - - - - - - - -
Announcement Date 22-11-10 23-02-22 23-05-03 23-08-08 23-11-07 24-02-21 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2022 2023 2024 2025
Net Debt - 154 - - -
Net Cash position 427 - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - 654 - - -
ROE (net income / shareholders' equity) 17.6% 7.9% - 9.55% 11.6%
ROA (Net income/ Total Assets) - - - 1.15% 1.18%
Assets 1 - - - 49,739 55,508
Book Value Per Share 2 - 14.40 - 27.50 31.70
Cash Flow per Share - 27.60 - - -
Capex - 32 - - -
Capex / Sales - 1.37% - - -
Announcement Date 20-02-26 23-02-22 24-02-21 - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
39.03 USD
Average target price
43 USD
Spread / Average Target
+10.17%
Consensus